Zacks Research Has Optimistic Outlook of Zoetis Q2 Earnings

Zoetis Inc. (NYSE:ZTS) – Zacks Research boosted their Q2 2025 earnings per share estimates for Zoetis in a research note issued on Wednesday, October 23rd. Zacks Research analyst E. Bagri now expects that the company will post earnings of $1.68 per share for the quarter, up from their prior forecast of $1.66. The consensus estimate for Zoetis’ current full-year earnings is $5.83 per share. Zacks Research also issued estimates for Zoetis’ FY2025 earnings at $6.43 EPS, Q2 2026 earnings at $1.80 EPS and FY2026 earnings at $7.00 EPS.

Several other brokerages have also recently weighed in on ZTS. JPMorgan Chase & Co. lifted their price target on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Piper Sandler lifted their price target on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, August 14th. Stifel Nicolaus lifted their price target on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research report on Wednesday, September 18th. Argus upgraded Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Finally, BTIG Research boosted their price objective on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, August 12th. Ten analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $221.44.

Zoetis Stock Down 0.3 %

Shares of ZTS stock opened at $188.99 on Thursday. The stock has a 50 day moving average of $189.23 and a 200 day moving average of $177.58. The company has a current ratio of 3.45, a quick ratio of 2.09 and a debt-to-equity ratio of 1.32. The stock has a market cap of $85.62 billion, a P/E ratio of 36.98, a P/E/G ratio of 2.94 and a beta of 0.89. Zoetis has a twelve month low of $144.80 and a twelve month high of $201.92.

Zoetis (NYSE:ZTS) last released its earnings results on Tuesday, August 6th. The company reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. Zoetis had a return on equity of 50.67% and a net margin of 26.29%. The firm had revenue of $2.36 billion during the quarter, compared to the consensus estimate of $2.31 billion. During the same quarter in the previous year, the company posted $1.41 earnings per share. The company’s revenue was up 8.3% compared to the same quarter last year.

Institutional Trading of Zoetis

A number of institutional investors have recently made changes to their positions in the company. Asset Dedication LLC boosted its stake in shares of Zoetis by 4.8% in the second quarter. Asset Dedication LLC now owns 1,174 shares of the company’s stock worth $204,000 after acquiring an additional 54 shares during the last quarter. Forza Wealth Management LLC boosted its stake in shares of Zoetis by 1.8% in the second quarter. Forza Wealth Management LLC now owns 3,313 shares of the company’s stock worth $574,000 after acquiring an additional 58 shares during the last quarter. Cherry Creek Investment Advisors Inc. boosted its stake in shares of Zoetis by 2.0% in the third quarter. Cherry Creek Investment Advisors Inc. now owns 3,021 shares of the company’s stock worth $590,000 after acquiring an additional 58 shares during the last quarter. L. Roy Papp & Associates LLP boosted its stake in shares of Zoetis by 2.8% in the second quarter. L. Roy Papp & Associates LLP now owns 2,221 shares of the company’s stock worth $385,000 after acquiring an additional 60 shares during the last quarter. Finally, Grove Bank & Trust boosted its stake in shares of Zoetis by 0.5% in the third quarter. Grove Bank & Trust now owns 11,763 shares of the company’s stock worth $2,298,000 after acquiring an additional 61 shares during the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st will be paid a $0.432 dividend. This represents a $1.73 dividend on an annualized basis and a dividend yield of 0.91%. The ex-dividend date of this dividend is Thursday, October 31st. Zoetis’s dividend payout ratio is presently 33.86%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.